Lummy: Product Nicorandil tablets intend to be selected for the 11th batch of national drug procurement

Lummy announced that the company participated in the bidding for the 11th batch of national centralized drug procurement, with the product Nicorandil tablets expected to be selected, with a proposed selection price of 2.95 yuan/box. The proposed selection quantity and the provinces to be supplied will be subject to final data. This product obtained its registration certificate in 2025 and has not been sold to date. If a procurement contract is signed and implemented subsequently, it will promote product sales and market expansion, enhancing brand influence. However, there are uncertainties regarding the signing of the procurement contract and other subsequent matters